FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance
Labs, patients, and technology must all work together to deliver forward-thinking patient-centered care.
How lab leaders can manage the data security risks of staff using personal devices for work-related purposes.
This BYOD policy template illustrates the basic issues lab leaders may want to address to ensure cybersecurity in their facilities.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.
How laboratories can avoid compliance issues involving certain marketing and staffing practices.
Missing small details or getting them wrong can be disastrous for a lab move—here’s how to avoid major issues.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
What lab leaders need to know about the FDA’s three new 510(k) draft guidances.
This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.